HGG Adv. 2025 Jul 31:100487. doi: 10.1016/j.xhgg.2025.100487. Online ahead of print.
ABSTRACT
We developed an imputation panel for Alzheimer’s disease (AD) and related dementias (ADRD) using 15,958 whole-genome sequencing (WGS) samples from the Alzheimer’s Disease Sequencing Project (ADSP). Recognizing the importance of associations between structural variants (SVs) and AD, and their underrepresentation in existing public reference panels, our panel uniquely integrates single nucleotide variants (SNVs), short insertions and deletions (indels), and SVs. This panel enhances the imputation of rare variants underlying disease susceptibility onto genotype array data, offering a cost-effective alternative to whole-genome sequencing while significantly augmenting statistical power. Notably, we discovered 10 rare indels nominal significant related to AD that are absent in the TOPMed-r2 panel and identified one genome-wide significant (P < 5 x 10-08) and three suggestive significant (P < 1 × 10-05) AD-associated SVs. These findings provide the other insights into AD genetics and underscore the critical role of imputation panels in advancing our understanding of complex diseases like ADRD.
PMID:40751311 | DOI:10.1016/j.xhgg.2025.100487
